Du C - Search Results

1

TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.

Xiao H, Jiang N, Zhou B, Liu Q, Du C. Xiao H, et al. Among authors: du c. Cancer Sci. 2015 Feb;106(2):151-9. doi: 10.1111/cas.12587. Epub 2015 Jan 30. Cancer Sci. 2015. PMID: 25495189 Free PMC article.

2

Tumor necrosis factor alpha 308 G/A polymorphism and hepatocellular carcinoma risk in a Chinese population.

Shi Z, Du C. Shi Z, et al. Among authors: du c. Genet Test Mol Biomarkers. 2011 Jul-Aug;15(7-8):569-72. doi: 10.1089/gtmb.2011.0008. Epub 2011 Mar 14. Genet Test Mol Biomarkers. 2011. PMID: 21401328

3

The effect of fibroblast activation on vascularization in transplanted pancreatic islets.

Liu D, Xiao H, Du C, Luo S, Li D, Pan L. Liu D, et al. Among authors: du c. J Surg Res. 2013 Jul;183(1):450-6. doi: 10.1016/j.jss.2012.12.044. Epub 2013 Jan 20. J Surg Res. 2013. PMID: 23369362

4

Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China.

Liao R, Yang J, Zhou BY, Li DW, Huang P, Luo SQ, Du CY. Liao R, et al. World J Surg Oncol. 2015 Jun 6;13:196. doi: 10.1186/s12957-015-0608-4. World J Surg Oncol. 2015. PMID: 26048469 Free PMC article.

5

Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery.

Liao R, Jiang N, Tang ZW, Li de W, Huang P, Luo SQ, Gong JP, Du CY. Liao R, et al. Oncotarget. 2016 May 24;7(21):30951-61. doi: 10.18632/oncotarget.9049. Oncotarget. 2016. PMID: 27129159 Free PMC article.

6

ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.

Xie YX, Liao R, Pan L, Du CY. Xie YX, et al. Immunol Lett. 2017 Aug;188:116-123. doi: 10.1016/j.imlet.2017.06.009. Epub 2017 Jun 28. Immunol Lett. 2017. PMID: 28668554

7

[Hepatic stellate cells inhibit the proliferation and invasion of HepG2 hepatocellular carcinoma via activating γδ T cells].

Fan K, Liao R, Xie Y, Peng C, Du C. Fan K, et al. Among authors: du c. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Jul;33(7):870-874. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017. PMID: 28712391 Chinese.

8

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.

Liao R, Peng C, Li M, Li DW, Jiang N, Li PZ, Ding X, Wu Q, Du CY, Gong JP. Liao R, et al. Among authors: du cy. Cancer Med. 2018 Apr;7(4):1170-1182. doi: 10.1002/cam4.1424. Epub 2018 Mar 13. Cancer Med. 2018. PMID: 29533004 Free PMC article.

9

The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma.

Xiao H, Zhou B, Jiang N, Cai Y, Liu X, Shi Z, Li M, Du C. Xiao H, et al. Among authors: du c. Genes Dis. 2018 Jan 31;5(2):167-171. doi: 10.1016/j.gendis.2018.01.003. eCollection 2018 Jun. Genes Dis. 2018. PMID: 30258946 Free PMC article.

10

An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.

Zhou BY, Gong JH, Cai XY, Wang JX, Luo F, Jiang N, Gong JP, Du CY, Liao R. Zhou BY, et al. Hepatol Int. 2019 Sep;13(5):631-640. doi: 10.1007/s12072-019-09969-w. Epub 2019 Jul 24. Hepatol Int. 2019. PMID: 31342250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,167 results

Search Page

Filters